ESO and WSO are holding virtual Large Clinical Trials sessions on May 13, 2020 | 13:00 – 14:30 CET. They are free to join, no pre-registration required. Just click the webinar registration link, add the date to your calendar and join us on the day.
Large Clinical Trials Session
ESO-WSO 2020 Webinar – May 13, 2020 | 13:00 – 14:30 CET
Moderators:
Jesse Dawson (UK)
Michael Brainin (Austria)
13:00 – 13:02 - Opening remarks by the chairs – 1-2 mins
13:02 – 13:17 - Trial 1: Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke (Effects) – presented by Erik Lundström (Sweden)
13:17 – 13:32 - Trial 2: Assessment of Fluoxetine in Stroke Recovery (Affinity): Results of a Double-blind, Placebo-controlled, Randomised Trial – presented by Graeme Hankey (Australia)
13:32 – 13:47 - Trial 3: A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectomy Preceded by Intravenous Alteplase in Acute Ischemic Stroke – presented by Jianmin Liu (China)
13:47 – 14:02 - Trial 4: The Basilar Artery International Collaboration Study (Basics): A Randomized Controlled Trial of Endovascular Therapy in Basilar Artery Occlusion – presented by Wouter Schonewille (Netherlands)
14:02 – 14:17 - Trial 5: Ascot Trial: The Effect of Randomisation to Atorvastatin or Placebo, and Amlodipine-based or Beta-blocker-based Regime on 20-year Incidence of Stroke or Dementia – presented by William Whiteley (UK)
14:17 – 14:30 – Closing remarks by the chairs and buffer time.
IMPORTANT: The chairs have decided to increase the time for presentation. They will call you by name and you will have 12 minutes to introduce yourself and start the presentation. After that you will have 3 minutes for answering questions. The chairs will choose the questions from the audience through the Q&A chat.
Corporate Supporters
Corporate Supporters
Platinum Plus
Platinum Plus
Silver
Silver
Silver
Silver
Silver
Bronze
Bronze
Bronze
Bronze
Member login